Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.

Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PLoS One. 2013; 8(4):e59981.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
gamma-Aminobutyric Acid
Humans
Male
Middle Aged
Neoplasms
Neuralgia
Oxycodone
Polymorphism, Single Nucleotide
Pregabalin
Treatment Outcome

authors with profiles

Marina Chiara Garassino